Recent genome-wide binding studies have confirmed that MYB, C/EBPβ, and p300 co-localize at many promoters and enhancer sites in AML cells [28], suggesting that these proteins form a regulatory transcriptional module in myeloid cells. The gene discussed is CEBPB; the disease is acute myeloid leukemia.